Menu
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.
5770 Armada Dr
Carlsbad, California 92008-4608
Phone: 17607278399
www.seaspine.com
https://www.investing.com/news/pro/outlook-moves-modestly-higher-post-earning--stifel-reiterates-seaspine-holdings-at-buy-with-16-price-target-432SI-2861557
SeaSpine Holdings Corp (NASDAQ:NASDAQ:SPNE) Q2 2022 Earnings Conference Call August 02, 2022, 16:30 ET Company Participants Leigh Salvo - Gilmartin Group Keith Valentine - President, CEO…
The following slide deck was published by SeaSpine Holdings Corporation in conjunction with their 2022 Q2 earnings call.
SeaSpine Holdings (NASDAQ: SPNE ) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings SeaSpine Holdings missed estimated earnings by 8.57%, reporting an EPS of $-0.38 versus an … Full story available on Benzinga.com
SeaSpine press release (SPNE): Q2 GAAP EPS of -$0.38 (vs
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Meridian Anterior Lumbar Interbody System featuring the Reef A interbody. This innovative, new ALIF (anterior lumbar interbody fusion) system addresses
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Meridian Anterior Lumbar Interbody System featuring the Reef A interbody. This innovative, new ALIF (anterior lumbar interbody fusion) system addresses an approximately $200 million dollar market segment in the U.S.
SeaSpine Holdings (NASDAQ: SPNE ) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here''s what investors need to know before the announcement. Analysts estimate that SeaSpine Holdings will report an earnings per share (EPS) of $-0.35. SeaSpine Holdings bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com
CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading on Tuesday, August 2, 2022. Members of the Company’s management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.
Here''s why we like SeaSpine, Recursion Pharmaceuticals, and Agenus.
SeaSpine holdings has continued to deliver a series of operating losses over the past two years to date.
Just in time for the summer season, Canopy Growth Corp. announced the continued expansion of its cannabis beverage portfolio and a brand campaign that drives awareness of its wide range of cannabis beverages. Canopy Growth continues to show its leadership in beverages and ongoing commitment to meeting customer demand. The company showcases its diverse portfolio…
The new ownership took the reins on June 2 at the facility in Boerne, Texas, which is about 20 minutes from San Antonio. It’s not immediately clear who the new resort owner is. “Ownership wishes to remain private,” says Caleb Dubose, Managing Director for Crescent Hotels & Resorts, which is managing the resort. The 111-room…
Company’s second fully commercialized interbody system featuring the novel WaveForm 3D printed technology and that addresses an estimated $200 million cervical market opportunity CARLSBAD, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today